{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2014:2UK4XAWEURXZP7XEKALOS4LSZ5","short_pith_number":"pith:2UK4XAWE","canonical_record":{"source":{"id":"1405.1275","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2014-05-06T14:04:22Z","cross_cats_sorted":[],"title_canon_sha256":"58745f96398f802788b5be177377541d2987eeafc971a1088d3cda365a59544d","abstract_canon_sha256":"1bc61067bbcf98782e106bd6c64a65e3839881a22496422acbae32d9eb564d28"},"schema_version":"1.0"},"canonical_sha256":"d515cb82c4a46f97fee45016e97172cf7854193d6af51724218d8522994b1a43","source":{"kind":"arxiv","id":"1405.1275","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1405.1275","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"arxiv_version","alias_value":"1405.1275v1","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1405.1275","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"pith_short_12","alias_value":"2UK4XAWEURXZ","created_at":"2026-05-18T12:28:11Z"},{"alias_kind":"pith_short_16","alias_value":"2UK4XAWEURXZP7XE","created_at":"2026-05-18T12:28:11Z"},{"alias_kind":"pith_short_8","alias_value":"2UK4XAWE","created_at":"2026-05-18T12:28:11Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2014:2UK4XAWEURXZP7XEKALOS4LSZ5","target":"record","payload":{"canonical_record":{"source":{"id":"1405.1275","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2014-05-06T14:04:22Z","cross_cats_sorted":[],"title_canon_sha256":"58745f96398f802788b5be177377541d2987eeafc971a1088d3cda365a59544d","abstract_canon_sha256":"1bc61067bbcf98782e106bd6c64a65e3839881a22496422acbae32d9eb564d28"},"schema_version":"1.0"},"canonical_sha256":"d515cb82c4a46f97fee45016e97172cf7854193d6af51724218d8522994b1a43","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T02:52:33.142637Z","signature_b64":"igx5ld5+dWYDHw6Ymsi/PZQ1/gzfL+tsa8FHjob9j5RwFAnJXO4QmihLzdYxhNIcHBrflyXTmTRqXGv9Ql5MDQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"d515cb82c4a46f97fee45016e97172cf7854193d6af51724218d8522994b1a43","last_reissued_at":"2026-05-18T02:52:33.142110Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T02:52:33.142110Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1405.1275","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T02:52:33Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"UeSfobuzn6POZXkJT2uShAHCTZwWgWhDwVrnSND7r+HXD4uHV85qBC0xTCpJgmAzueYFu/r/mOYwZnCb1eRnBw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-09T23:26:44.404922Z"},"content_sha256":"e7f4414fbf22466bad67f8221a8584d06ad0585235c6a06790507e783bb0df91","schema_version":"1.0","event_id":"sha256:e7f4414fbf22466bad67f8221a8584d06ad0585235c6a06790507e783bb0df91"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2014:2UK4XAWEURXZP7XEKALOS4LSZ5","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Andrew Wey, Joseph S. Koopmeiners","submitted_at":"2014-05-06T14:04:22Z","abstract_excerpt":"The primary object of a phase I clinical trial is to determine the maximum tolerated dose (MTD). Typically, the MTD is identified using a dose-escalation study, where initial subjects are treated at the lowest dose level and subsequent subjects are treated at progressively higher dose levels until the MTD is identified. The continual reassessment method (CRM) is a popular model-based dose-escalation design, which utilizes a formal model for the relationship between dose and toxicity to guide dose-finding. Recently, it was shown that the CRM has a tendency to get \"stuck\" on a dose-level, with l"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1405.1275","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T02:52:33Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"Z0pgouYgOn1VGC+/nbBZ5sZFsrcayhHjCWQd3FL2pIrgLTUFg5z6bDtBpewm1DoPNXpLYhQQUrVA1tMSkL5qDw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-09T23:26:44.405678Z"},"content_sha256":"1499f91291f3ed0533e285d7faa51d6879f83f1219b6340f883b542f3c1545f8","schema_version":"1.0","event_id":"sha256:1499f91291f3ed0533e285d7faa51d6879f83f1219b6340f883b542f3c1545f8"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/bundle.json","state_url":"https://pith.science/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-09T23:26:44Z","links":{"resolver":"https://pith.science/pith/2UK4XAWEURXZP7XEKALOS4LSZ5","bundle":"https://pith.science/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/bundle.json","state":"https://pith.science/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/state.json","well_known_bundle":"https://pith.science/.well-known/pith/2UK4XAWEURXZP7XEKALOS4LSZ5/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2014:2UK4XAWEURXZP7XEKALOS4LSZ5","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"1bc61067bbcf98782e106bd6c64a65e3839881a22496422acbae32d9eb564d28","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2014-05-06T14:04:22Z","title_canon_sha256":"58745f96398f802788b5be177377541d2987eeafc971a1088d3cda365a59544d"},"schema_version":"1.0","source":{"id":"1405.1275","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1405.1275","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"arxiv_version","alias_value":"1405.1275v1","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1405.1275","created_at":"2026-05-18T02:52:33Z"},{"alias_kind":"pith_short_12","alias_value":"2UK4XAWEURXZ","created_at":"2026-05-18T12:28:11Z"},{"alias_kind":"pith_short_16","alias_value":"2UK4XAWEURXZP7XE","created_at":"2026-05-18T12:28:11Z"},{"alias_kind":"pith_short_8","alias_value":"2UK4XAWE","created_at":"2026-05-18T12:28:11Z"}],"graph_snapshots":[{"event_id":"sha256:1499f91291f3ed0533e285d7faa51d6879f83f1219b6340f883b542f3c1545f8","target":"graph","created_at":"2026-05-18T02:52:33Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"The primary object of a phase I clinical trial is to determine the maximum tolerated dose (MTD). Typically, the MTD is identified using a dose-escalation study, where initial subjects are treated at the lowest dose level and subsequent subjects are treated at progressively higher dose levels until the MTD is identified. The continual reassessment method (CRM) is a popular model-based dose-escalation design, which utilizes a formal model for the relationship between dose and toxicity to guide dose-finding. Recently, it was shown that the CRM has a tendency to get \"stuck\" on a dose-level, with l","authors_text":"Andrew Wey, Joseph S. Koopmeiners","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2014-05-06T14:04:22Z","title":"The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1405.1275","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:e7f4414fbf22466bad67f8221a8584d06ad0585235c6a06790507e783bb0df91","target":"record","created_at":"2026-05-18T02:52:33Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"1bc61067bbcf98782e106bd6c64a65e3839881a22496422acbae32d9eb564d28","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2014-05-06T14:04:22Z","title_canon_sha256":"58745f96398f802788b5be177377541d2987eeafc971a1088d3cda365a59544d"},"schema_version":"1.0","source":{"id":"1405.1275","kind":"arxiv","version":1}},"canonical_sha256":"d515cb82c4a46f97fee45016e97172cf7854193d6af51724218d8522994b1a43","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"d515cb82c4a46f97fee45016e97172cf7854193d6af51724218d8522994b1a43","first_computed_at":"2026-05-18T02:52:33.142110Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T02:52:33.142110Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"igx5ld5+dWYDHw6Ymsi/PZQ1/gzfL+tsa8FHjob9j5RwFAnJXO4QmihLzdYxhNIcHBrflyXTmTRqXGv9Ql5MDQ==","signature_status":"signed_v1","signed_at":"2026-05-18T02:52:33.142637Z","signed_message":"canonical_sha256_bytes"},"source_id":"1405.1275","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:e7f4414fbf22466bad67f8221a8584d06ad0585235c6a06790507e783bb0df91","sha256:1499f91291f3ed0533e285d7faa51d6879f83f1219b6340f883b542f3c1545f8"],"state_sha256":"7b45d79ccd3193bba9a56706020928d4a090085621296c309d15b28402962bda"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"PMoCGmR81nzNGYvWVpI/+ZnUgnT5aiCIf6ZHlYnr7q7Wn9c4svg9Sey+fUpxiGvabfIdyHlU97MzQhvXxdO9CA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-09T23:26:44.410436Z","bundle_sha256":"71d4f927678573747e2e7e8c62638cf95725ca3529b455757ae493ca8cfb52ff"}}